| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8459613 | Radiotherapy and Oncology | 2014 | 9 Pages |
Abstract
Compared to the ITV, the MidP significantly reduced PTV and doses to OARs. MidP is safe for helical delivery except for very small tumors (<5Â cc) with large-amplitude motion (>10Â mm) where the ITV might remain the most adequate approach.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Marie Wanet, Edmond Sterpin, Guillaume Janssens, Antoine Delor, John Aldo Lee, Xavier Geets,